At a Glance
- Sarah Jessica Parker, 60, has been coping with age-related blurry near vision for roughly fifteen years
- The actress calls reading glasses “the biggest annoyance” after decades of reading without aid
- She now uses FDA-approved Vizz drops and is partnering with Lenz Therapeutics to promote the treatment
- Why it matters: The condition affects 128 million Americans and can disrupt daily tasks like reading and texting
Fifteen years after her first struggle to read a book in an Irish hotel room, Sarah Jessica Parker has found relief from age-related blurry near vision. The 60-year-old actress and publisher tells News Of Losangeles that new FDA-approved eye drops have restored the freedom she once took for granted.
Trouble on the Page
Parker recalls the night her vision first faltered. She was in Ireland, settling in with a book before bed, when the words refused to come into focus.
“I just remember reading and thinking, ‘This isn’t comfortable and this isn’t fun,'” she says. “Initially I just thought, ‘Oh, my eyes are tired or I’m tired.’ But it became abundantly clear that it was the obvious.”
That moment marked the start of a frustrating dependency on reading glasses. Parker, who had prided herself on reading anywhere-“in the dark, I read in cars”-now had to keep a pair within reach.
“It was the biggest annoyance needing something to do what I had spent so many years just doing wherever and whenever I wanted,” she explains.
A Life Built on Reading
Reading is central to Parker’s identity. Last year alone, while serving as a judge for the 2025 Booker Prize, she read more than 150 books, all while battling her vision troubles.
“I love reading. It’s also my job,” she says, referencing her roles as actress, publisher, and parent. “But I’m not somebody who spends a lot of time bemoaning. Like, I just don’t complain. I’m always just kind of marching ahead and doing what I need to do.”
Still, the constant search for glasses slowed her down. She describes the routine: “reaching the depths of my purse, touching my body, looking in a bag, on a countertop for a pair of glasses.”
Discovering Vizz
Parker’s frustration led her to Vizz, a prescription eye drop developed by Lenz Therapeutics. The FDA approved Vizz in 2025 for treating age-related blurry near vision, a condition that affects roughly 128 million Americans.
After several months of using the drops, Parker says the change is practical and immediate.
“Having discovered Vizz and having something that created more convenience, just on a practical level, is really fantastic,” she says. “I can pick up a book anytime, anywhere. I can text anytime, anywhere.”
A New Partnership
Parker is now working with Lenz Therapeutics to raise awareness of the treatment. She frames the partnership as a natural extension of her lifestyle.
“There’s things that I wanna do to support something like my relationship with reading,” she says. “It’s like, ‘Oh yeah, this is the way I can live my life differently.'”
She emphasizes that the choice felt low-risk. “It didn’t seem like something radical for me,” she adds, noting that the drops simply help her eyes “be my buddy.”
Aging Out of Sight
Free from the daily hunt for glasses, Parker says she can return to her preferred mindset: not dwelling on aging.
“I carry on in the same way I always have,” she quips. “I’m not somebody who’s spent a lot of time talking about aging, self-care, any of that. I don’t even talk about my birthdays.”
The ability to read without interruption, she says, was worth acknowledging. “It’s nice to be able to pick up a book and read, and this didn’t exist a year ago in my life, so that’s really nice.”
Key Takeaways
- Age-related blurry near vision struck Parker about 15 years ago during a trip to Ireland
- The condition forced her to rely on reading glasses, disrupting her lifelong reading habits
- Vizz eye drops, approved by the FDA in 2025, now let her read and text without glasses
- Parker hopes sharing her story encourages others to ask their doctors about treatment options
